Organization Profile

You just read:

Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase II Clinical Trial Investigating REOLYSIN® in Combination with Gemcitabine in Patients with Advanced or Metastatic Pancreatic Cancer

News provided by

Oncolytics Biotech Inc.

Oct 24, 2012, 06:30 ET